The adoption of accurate non-invasive measures of liver health at the point of care is critical.
Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.
Technology isn’t the only driver in this change; the sociological factor plays a role as well.
As the Internet of Things and the reimbursement environment transform the healthcare ecosystem, device manufacturers must position themselves to adapt.
How do marketing messages affect third-party payers?
Payer organizations face a host of issues in the conversion to ICD-10.
Identify the roadmap through which you’re evolving with the changing healthcare landscape.
Successful accountable care organizations consist of a superior confluence of quality efforts, physician engagement, patient engagement, the right administration and the ability to keep costs down. The challenge comes in balancing these efforts while keeping costs to a minimum.
This Q&A session, with an active Regional Medical Director involved in traditional health plan policy and payment development, as well as emerging value-based models, reveals important information and attitudes toward coverage of new/existing technologies and standards of evidence.
Presenting clinical evidence to payers is the most efficient method of gaining coverage. But when this strategy is unsuccessful or hits a wall, a ground-up approach is required, relying on consistent and steady support from local physician champions that demonstrates broad acceptance of a technology.